feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Coca-Cola faces plastic criticism

trending

Texans upset Kansas City Chiefs

trending

Caitlin Clark declined overseas offer

trending

Taylor Swift at Texans game?

trending

Guilford County schools early dismissal

trending

Golden Globes nominations unveiled December

trending

Walmart Lexington bomb threat

trending

Todd Combs joins JPMorgan

trending

IBM nears Confluent acquisition

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / KGMU Expands Free Train Travel for Serious Illnesses

KGMU Expands Free Train Travel for Serious Illnesses

7 Dec

•

Summary

  • Free train travel for patients expands to eight new serious conditions.
  • A new railway ticket counter will be set up on the KGMU campus.
  • Eligible patients and one attendant get free sleeper or third AC travel.
KGMU Expands Free Train Travel for Serious Illnesses

King George's Medical University (KGMU) is set to significantly broaden its free train travel facility for patients suffering from severe illnesses. This expansion, currently awaiting approval, will extend the benefit to cover eight new disease categories, including Japanese encephalitis, dengue, swine flu, and Covid-19, in addition to existing provisions for cancer, heart, liver, and kidney diseases.

The initiative, a collaboration with the railways, aims to ease the financial strain on patients, particularly those from low-income backgrounds, who frequently travel for medical treatment and follow-up appointments. A dedicated railway ticket reservation counter will also be established on the KGMU campus to streamline the booking process.

Eligible patients, including ration card holders and beneficiaries of government health schemes, along with one attendant, will be entitled to free travel in sleeper class or third AC. Options for second AC and first AC tickets at a discounted rate will also be available. Doctors will note follow-up dates on prescriptions for patients to present at the counter.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The KGMU scheme now covers eight additional serious diseases, including Japanese encephalitis, dengue, swine flu, and Covid-19, alongside existing provisions.
Eligible patients include ration card holders, Antyodaya Anna Yojana beneficiaries, and those under the Prime Minister's Jan Arogya Yojana.
Patients can present their doctor's prescription with the next follow-up date at the new railway reservation counter on the KGMU campus.

Read more news on

Healthside-arrow

You may also like

Stay Warm & Safe: Your Winter Survival Guide

3 Dec • 30 reads

article image

Bird Flu Surges Early Across Continents

28 Nov • 78 reads

article image

Whooping Cough Surges: Are Vaccines Failing?

19 Nov • 101 reads

article image

Cervical Cancer Elimination: KGMU's Three-Pronged Attack

18 Nov • 64 reads

article image

mRNA Vaccine Trial Targets Epstein-Barr Virus to Treat Multiple Sclerosis

18 Nov • 70 reads

article image